>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>MS049

MS049

Catalog No.GC36656

MS049는 각각 34nM 및 43nM의 IC50을 갖는 PRMT4 및 PRMT6의 강력하고 선택적인 세포 활성 이중 억제제입니다. MS049는 HEK293 세포에서 Med12me2a 및 H3R2me2a의 수준을 감소시킵니다. MS049는 독성이 없으며 HEK293 세포의 성장에 영향을 미치지 않습니다.

Products are for research use only. Not for human use. We do not sell to patients.

MS049 Chemical Structure

Cas No.: 1502816-23-0

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$67.00
재고 있음
5mg
US$61.00
재고 있음
10mg
US$102.00
재고 있음
25mg
US$222.00
재고 있음
50mg
US$408.00
재고 있음
100mg
US$742.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 of 34 nM and 43 nM respectively.target: PRMT4, PRMT6;IC 50: 34 nM (PRMT4 ), 43 nM (PRMT6 );In vitro: MS 049 reduces the H3R2me2a mark in HEK293 cells in a concentration dependent manner. MS 049 treatment (72 h exposure) inhibits endogenous PRMT4 methyltransferase activity in a concentration dependent manner resulting in reduced levels of cellular asymmetric arginine dimethylation of Med12 (Med12-Rme2a, IC50 = 1.4 ± 0.1 μM (n = 3)) in HEK293 cells.

[1]. Shen Y et al. Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6. J Med Chem. 2016 Sep 15.

리뷰

Review for MS049

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MS049

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.